ISPOR 20th Annual European Congress

The ISPOR Annual European Congress opens next weekend, exploring the 'Evolution of Value in Healthcare'.

It's a great chance to learn more about our work, and to meet researchers working in key areas of health economics policy and methods development.

Short courses

• Development of Conceptual Models
  Saturday 4 November
  8.00am - 12 noon
  with Beth Woods
• Mapping to Estimate Utility Values from Non-Preference Based Outcome Measures
  Sunday 5 November
  8.00am - 12 noon
  with Andrea Manca

Issues panels

• IP4: Value Added Medicines: Time to Adjust the Health Technology Assessment Decision Frameworks?
  Monday 6 November
  2.15 - 3.15pm
  with Michael Drummond

• IP10: Does Valuation of Innovation in Appraisal of New Technologies Provide Appropriate Incentives for Manufacturers and Access for Patients?
  Tuesday 7 November
  8.45 - 9.45am
  with Mark Sculpher and Karl Claxton
• IP16: Managed Entry Schemes for Medical Devices: Great Opportunity or Major Challenge?
  Tuesday 7 November
  4.45 - 5.45pm
  with Michael Drummond

Workshops

• W5: Sustainable Funding and Fair Pricing for Orphan Drugs: What are the Solutions?
  Monday 6 November
  3.45 - 4.45pm
  with Michael Drummond
• W6: Generating Real-world Evidence for Real-world Decisions: Application of Advanced Methods
  Monday 6 November
  3.45 - 4.45pm
  with Mark Sculpher
• W7: Value of Information Analysis for Research Decisions: Emerging Good Practice Recommendations from the ISPOR VOI Task Force
  Monday 6 November
  5.00 - 6.00pm
  with Claire Rothery
• W15: Time for a Change? Alternative Approaches to Modelling in Cancer Value Assessments
  Tuesday 7 November
  4.45 - 5.45pm
  with Beth Woods and Marta Soares
• W19: Generating Evidence to Support Off-label Higher Value Cancer Treatment Regimens
  Wednesday 8 November
  10.00 - 11.00am
  with Mark Sculpher

Educational symposia

• Universal Value: The Way Forward?
  Wednesday 8 November
  7.30 - 8.30am
  with Michael Drummond

Podium presentations

• P4: Research on Methods
  Monday 6 November
  2.15 - 3.15pm
  with Andrea Manca
• P9: Medical Device and Diagnostics Studies MD3: Cost-effectiveness of Diagnosis: From Tests to Long-term Outcomes and Costs
  Tuesday 7 November
  8.45 - 9.45am
  with Rita Faria

Posters

• PMD88: Cost-effectiveness of High-throughput, Non-invasive Prenatal Testing for Fetal Rhesus D Status
  Tuesday 7 November
  8.45am - 1.30pm (author discussion 12.30 - 1.30pm)
  with Pedro Saramago Goncalves
• PCV83: The Impact of Missed Treatment Opportunities in Outcomes in Hospitalised Heart Failure Patients: Modelling Analysis Based on the National Heart Failure Audit
  Tuesday 7 November
  8.45am - 1.30pm (author discussion 12.30 - 1.30pm)
  with Simon Walker
• PMD115: Public Perceptions, Attitudes and Willingness to Pay Towards a Medical Device for Detecting Foot Ulceration in People with Diabetes
  Tuesday 7 November
  8.45am - 1.30pm (author discussion 12.30 - 1.30pm)
  with Fan Yang
• PRM143: Tackling Network Meta-analysis Methodological Challenges: A case Study on Biologic Treatments for Moderate to Severe Plaque Psoriasis in Children and Young People
  Wednesday 8 November
  8.45am - 2.00pm (author discussion 1.00 - 2.00pm)
  with Ana Duarte